Newcastle Disease Virus Induces Pyroptosis in Canine Mammary Tumour CMT ‐ U27 Cells via the TNFα / NF ‐ κB / NLRP3 Signalling Pathway
Veterinary and Comparative Oncology · 2025-06 · 23 (2) · 224-235
DOI: 10.1111/vco.13048 ↗Abstract
ABSTRACT Mammary tumours are the most common type of neoplasm in female dogs, with nearly half being malignant. Oncolytic Newcastle disease virus (NDV) therapy has emerged as a novel cancer treatment option; however, its precise oncolytic mechanism in canine mammary tumours (CMT) remain unclear. Ultrastructural analysis of NDV‐infected CMT‐U27 cells with locally damaged cell membranes and swollen and ruptured mitochondria revealed the occurrence of pyroptosis. Transcriptome sequencing further identified a significant upregulation of pyroptosis‐related genes, including NLRP1, NOD2, caspase‐1, and GSDMD. Subsequent examination of RNA and protein expression levels of pyroptosis‐related molecules in vitro indicated that NDV induces pyroptosis in CMT‐U27 cells via the caspase‐1/GSDMD pathway. Additionally, inhibition of the TNFα/NF‐κB pathway and knockdown of NOD‐like receptor pyrin domain‐containing protein 3 (NLRP3) using small interfering RNA demonstrated that the TNFα/NF‐κB pathway can regulate NDV‐induced pyroptosis through the NLRP3 inflammasome. In a xenograft model, intravenous administration of NDV significantly inhibited tumour growth, and prolonged the survival time in nude mice bearing CMT‐U27 cells. NDV treatment enhances intratumoural pyrotosis in tumour bearing mice. In conclusion, these findings suggest that NDV induces pyroptosis in CMT‐U27 cells through the TNFα/NF‐κB/NLRP3 pathway, providing a foundation for future research into NDV's therapeutic potential in canine mammary cancer.
EUVIMED